Vertex Pharmaceuticals (VRTX) Inventory Average (2011 - 2026)

Vertex Pharmaceuticals' Inventory Average history runs 16 years deep, the most recent figure standing at $1.7 billion for Q1 2026.

• In Q1 2026, Inventory Average rose 34.63% year-over-year to $1.7 billion; the TTM figure through Mar 2026 stood at $1.7 billion (up 34.63% YoY), while the FY2025 annual figure was $1.4 billion, up 48.76% from the prior year.
• Inventory Average for Q1 2026 stood at $1.7 billion, up from $1.7 billion in the prior quarter.
• The five-year high for Inventory Average was $1.7 billion in Q1 2026, with the low at $346.0 million in Q1 2022.
• The 5-year median for Inventory Average is $775.9 million (2024), against an average of $903.9 million.
• The sharpest annual moves came in 2022 and 2023: Inventory Average climbed 13.88% in 2022, then soared 70.95% in 2023.
• Vertex Pharmaceuticals' Inventory Average stood at $424.4 million in 2022, then surged by 68.18% to $713.8 million in 2023, then surged by 60.08% to $1.1 billion in 2024, then jumped by 45.0% to $1.7 billion in 2025, then rose by 4.22% to $1.7 billion in 2026.
• Business Quant data shows VRTX's Inventory Average at $1.7 billion in Q1 2026, $1.7 billion in Q4 2025, and $1.6 billion in Q3 2025.